Literature DB >> 17315948

Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation.

Zhijie Qin1, Dongmei Hu, Min Zhu, Anthony L Fink.   

Abstract

Immunoglobulin light chain deposition diseases involve various types of extracellular deposition of light chain variable domains, including amyloid fibrils and amorphous deposits. The decreased thermodynamic stability of the light chain is believed to be the major factor leading to fibrillation. However, the differences in the nature of the deposits among the light chain deposition diseases raise the question of whether the mechanisms leading to fibrillar or amorphous aggregation is different. In this study, we generated two partially folded intermediates of the light chain variable domain SMA in the presence of guanidine hydrochloride (GuHCl) and characterized their conformations. The more unfolded intermediate formed fibrils most rapidly, while the more native-like intermediate predominantly led to amorphous deposits. The results also show that the monomeric, rather than the dimeric state, was critical for fibrillation. The data also indicate that fibril elongation involves addition of a partially unfolded intermediate, rather than the native state. We postulate that a more highly unfolded intermediate is more suited to undergo the topological rearrangements necessary to form amyloid fibrils than a more structured one and that this also correlates with increased destabilization. In the case of light chain aggregation, it appears that more native-like intermediate conformations are more prone to form amorphous deposits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17315948     DOI: 10.1021/bi061716v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  38 in total

1.  Comparison of amyloid fibril formation by two closely related immunoglobulin light chain variable domains.

Authors:  Douglas J Martin; Marina Ramirez-Alvarado
Journal:  Amyloid       Date:  2010-09       Impact factor: 7.141

2.  Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils.

Authors:  Ruiyi Ren; Zhenning Hong; Haiyan Gong; Kate Laporte; Martha Skinner; David C Seldin; Catherine E Costello; Lawreen H Connors; Vickery Trinkaus-Randall
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

3.  Altered dimer interface decreases stability in an amyloidogenic protein.

Authors:  Elizabeth M Baden; Barbara A L Owen; Francis C Peterson; Brian F Volkman; Marina Ramirez-Alvarado; James R Thompson
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

4.  Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies.

Authors:  Santosh V Thakkar; Neha Sahni; Sangeeta B Joshi; Bruce A Kerwin; Feng He; David B Volkin; C Russell Middaugh
Journal:  Protein Sci       Date:  2013-08-19       Impact factor: 6.725

5.  A multi-pathway perspective on protein aggregation: implications for control of the rate and extent of amyloid formation.

Authors:  Damien Hall; József Kardos; Herman Edskes; John A Carver; Yuji Goto
Journal:  FEBS Lett       Date:  2015-01-31       Impact factor: 4.124

6.  The structure of a folding intermediate provides insight into differences in immunoglobulin amyloidogenicity.

Authors:  Matthias J Feige; Sandra Groscurth; Moritz Marcinowski; Zu Thur Yew; Vincent Truffault; Emanuele Paci; Horst Kessler; Johannes Buchner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

Review 7.  Systemic amyloidoses.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

8.  Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.

Authors:  Bonnie K Arendt; Marina Ramirez-Alvarado; Laura A Sikkink; Jonathan J Keats; Gregory J Ahmann; Angela Dispenzieri; Rafael Fonseca; Rhett P Ketterling; Ryan A Knudson; Erin M Mulvihill; Renee C Tschumper; Xiaosheng Wu; Steven R Zeldenrust; Diane F Jelinek
Journal:  Blood       Date:  2008-06-20       Impact factor: 22.113

9.  Influence of the valine zipper region on the structure and aggregation of the basic leucine zipper (bZIP) domain of activating transcription factor 5 (ATF5).

Authors:  Natalie A Ciaccio; T Steele Reynolds; C Russell Middaugh; Jennifer S Laurence
Journal:  Mol Pharm       Date:  2012-10-23       Impact factor: 4.939

Review 10.  Mechanism of suppression of protein aggregation by α-crystallin.

Authors:  Kira A Markossian; Igor K Yudin; Boris I Kurganov
Journal:  Int J Mol Sci       Date:  2009-03-19       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.